Search Results: keywords:"pharmaceutical patents"

  • H. R. 9070 — To amend title 35, United States Code, to prohibit product hopping, and for other purposes.
    💰
    Status:Introduced in House
    Words:1,245

    H.R. 9070, known as the "Affordable Prescriptions for Patients Act of 2024," aims to amend Title 35 of the United States Code to make it harder for companies to engage in "product hopping," a strategy used to delay generic competition for pharmaceuticals. The bill allows the sponsor of an...

    Simple Explanation

    H.R. 9070 is a bill that plans to stop medicine companies from using tricks to keep their drugs more expensive for longer and adds a lot of money to help old people get healthcare through Medicare.

  • H. R. 6986 — To address patent thickets.
    Status:Introduced in House
    Words:684

    H.R. 6986 is a bill introduced in the House of Representatives that aims to manage the issue of patent thickets, particularly in the pharmaceutical and biological product sectors. The bill proposes limiting the number of patents that can be asserted in a lawsuit for infringement to one per...

    Simple Explanation

    H.R. 6986 is a new idea that tries to make it fairer when people argue about who owns special ideas for medicines. It says that if you have a bunch of ideas that are very close to each other, you can only use one at a time in a big fight about who thought of it first.